The AMR DxC Summer School India 2017
AMR has taken the centre stage internationally and now global campaigns raise awareness for this burning threat to global health. The importance of the role for rapid diagnostics to tackle Antimicrobial Resistance needs to be developed and use diagnostics in an economically sustainable way. Antimicrobial Resistance and the development and introduction of innovative diagnostics that transform healthcare are huge challenges which can be only overcome by collaboration across disciplines, countries, healthcare systems and economies. Innovation is also needed how the brightest minds can be attracted to the field. That is why AMR DxC, the international Antimicrobial Resistance Diagnostics Challenge competition, is developed to galvanise the next generation of researchers into action. The objectives of AMR DxC are to connect and inspire fresh scientific talent, spark off ideas and create a network for international, interdisciplinary and innovative R&D on AMR diagnostics.
The World Health Organization launched the first World Antibiotic Awareness Week 16th -22nd November 2015. The importance of AMR as a threat for public health and economic growth for India and UK has been underscored. It was reported that both Prime Ministers of India and UK recognised that a global response is required and supported a high level meeting on antimicrobial resistance at the 2016 UN General Assembly as well as a global summit on AMR. AMR DxC kicked off with a bilateral UK-India Autumn School in Edinburgh in 2015.
This workshop will give a overview of current research related to the field and also an opportunity to discover interesting connections. We are looking to identify well-defined research questions with probable solutions. These new questions might help to address long-standing questions of AMR Diagnostics. We look forward to welcome you all to Bangalore!
For more information on the AMR DxC India 2017 workshop, kindly contact Dr. Papri Banerjee at: email@example.com
Harnessing science & technology for better future
The Indian and UK Prime Ministers, Narendra Modi and Theresa May noted that the exponential growth in science and technology programmes in India provide immense possibilities for further expanding bilateral collaboration. India-UK joint funding now stands at over £200 million and its leveraged impact on the economies and societies is several times higher.
They announced new research partnerships worth £80 million including a new Joint Strategic Group on Anti-Microbial Resistance (AMR) with a joint investment of up to £13 million. The prime ministers recognised that Anti-Microbial Resistance (AMR) is a global challenge, and further recognised the commitments made at the G20 and UNGA earlier this year.
For more information on UK India policy: